Today: 30 June 2026
CrowdStrike stock sinks on insider sale plan as ‘software-mageddon’ rout bites CRWD
6 February 2026
1 min read

CrowdStrike stock sinks on insider sale plan as ‘software-mageddon’ rout bites CRWD

New York, Feb 5, 2026, 7:33 p.m. EST — After-hours

  • Shares of CrowdStrike dropped 9.2% in after-hours trading from their last close
  • A Form 144 filing showed a possible sale of 252,538 shares via J.P. Morgan
  • The drop comes as U.S. software stocks tumble again, rattled by fresh concerns over AI disruption

CrowdStrike Holdings’ shares plunged again in after-hours trading Thursday, dropping 9.2% to $377.16. The slide came after heavy losses earlier in the day, as investors backed away from software stocks.

The selloff has gone broad, now dragging down software and cybersecurity—two sectors that had held firm on steady spending and recurring revenue. This shift is significant.

U.S. software and data services shares have dropped for a seventh day running as concerns mount over AI tools potentially undercutting pricing power and reshaping demand. Investors are pulling back from high-multiple growth stocks, favoring more defensive sectors.

Pressure intensified after a Form 144 filing showed the PK Giving Trust, tagged as an affiliate, may sell 252,538 CrowdStrike shares through J.P. Morgan Securities. The shares are valued around $104.9 million.

A Form 144 gets filed whenever an affiliate plans to sell restricted or control securities. This filing often draws notice, even if no sales end up happening.

The filing coincided with CrowdStrike’s announcement of a memorandum of understanding with Saudi Arabia’s Aramco. This marks the first step toward exploring deeper collaboration on cybersecurity and “in-country cloud capabilities,” among other projects. CrowdStrike

“We’re proud to collaborate with Aramco as Saudi Arabia accelerates its secure AI adoption,” CEO George Kurtz said in the statement.

Thursday’s moves suggested macro trends and positioning mattered more than headlines. Cybersecurity names such as Palo Alto Networks dropped, tracking the broader software sector’s downturn.

Investors are debating whether the stock’s decline signals wider sector troubles or is tied to company-specific problems, especially with software trading volumes spiking this week.

The risk is straightforward: a spike in insider-sale plans could put a lid on rallies. If big clients start cutting budgets or AI shifts spending priorities, growth forecasts could take another hit.

CrowdStrike will report its Q4 and full-year results on March 3, right after the U.S. market closes. Investors will be watching closely for updates on demand and customer retention.

Khadija Saeed is a financial markets reporter at TS2.tech, specializing in stocks, technology and emerging industries. She studied economics and finance at the London School of Economics and previously worked in market research before moving into financial journalism. Her coverage focuses on the companies, innovations and economic trends influencing global investors.

Stock Market Today

  • Theravance Biopharma (TBPH) Slides 3% After $929M Zymeworks (ZYME) Deal Announced
    June 30, 2026, 10:24 AM EDT. Theravance Biopharma (TBPH) shares slipped about 3% on June 29, 2026, after Zymeworks (ZYME) said it would buy the company in an all-cash deal valued at around $929 million. The deal is set to close in H2 2026. Theravance went up for sale after its main drug, ampreloxetine, missed in Phase III trials. Most of Theravance's revenue came from a single COPD collaboration. The buyout gives shareholders $17 per share, which is a 22% premium to the March 3 close, plus CVRs linked to future ampreloxetine proceeds. Management called the move the best route for shareholder value as operational cuts and slow growth continue. Theravance has a Zacks Rank #4 (Sell).
NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next
Previous Story

NIO stock jumps after profit alert flags first quarterly operating profit — what investors watch next

Ford stock slips before market open as EV sales dive and Geely talks linger
Next Story

Ford stock slips before market open as EV sales dive and Geely talks linger

Go toTop